Blue Earth Diagnostics and GE Healthcare (NYSE:GE) said today that the group has inked a deal to establish the manufacturing of Blue Earth Diagnostic’s positron emission tomography imaging product, Axumin, in the U.K. The agreement with GE Healthcare is part of Blue Earth Diagnostics’ move towards commercializing Axumin since it won marketing authorization from the European […]
Diagnostics
Researchers find biomarker that could help diagnose CTE in living people
Chronic traumatic encephalopathy, a degenerative neurological disease found in the brains of athletes and others with a history of repetitive hits to the head, is hard for researchers to pin down. The disease’s prevalence is not known and it is only after death that scientists can confirm if someone was suffering from CTE. But now, […]
BD launches fully-automated diagnostic to fight antimicrobial resistance in Europe
Becton Dickinson (NYSE: BDX) today launched the first automated phenotypic diagnostic test for infections caused by carbapenemase-producing organisms. The new BD Phoenix CPO test is available as part of the BD Phoenix automated microbiology system in Europe, the company said, and is designed to help hospitals detect and contain infections caused by CPOs. Carbapenemase-producing organisms are resistant […]
Siemens Healthineers lands CE Mark for Atellica advanced diagnostics system
Siemens Healthineers (NYSE:SI) said today that its Atellica Solution won CE Mark and that the advanced diagnostic system is now available in Europe, the U.S., South America and Asia. The system consists of scalable immunoassay and chemistry analyzers, the company said, and can operate as a stand-alone system or connect to Aptio Automation. “The launch […]
Arkray launches diabetes diagnostic tech
Arkray‘s U.S. subsidiary launched today its Adams A1c HA-8180V system for hemoglobin A1c testing. The device is indicated to help diagnose and monitor people with diabetes, the Edina, Minn.-based company reported. “We are excited to bring this technology to the U.S. market. The ADAMS A1c HA-8180V builds on proven expertise. The Adams brand has been used globally […]
Medtech stories we missed this week: Sept. 15, 2017
From Acera Surgical and Telos Medical’s partnership to Xtant Medical’s 510(k) clearance, here are seven medtech stories we missed this week but thought were still worth a mention. 1. Acera Surgical partners with Telos Medical for Restrata wound matrix trial Telos Partners announced in a Sept. 14 press release that Acera Surgical has chosen Telos to […]
Study suggests Type II diabetes is being misdiagnosed in African-Americans
A test used to diagnose Type II diabetes and monitor blood sugar levels could be leaving hundreds of thousands of diabetic African Americans in the U.S. undiagnosed, according to a study published today in PLOS Medicine. The test uses 60 genetic variants, according to a team of scientists, and one of those genetic variants is found […]
Medtech stories we missed this week: September 8, 2017
From BrainScope’s pediatric traumatic brain injury assessment device to EOS Imaging releasing new surgery planning software, here are seven medtech stories we missed this week but thought were still worth a mention. 1. BrainScope to develop pediatric traumatic brain injury assessment device BrainScope announced in a Sept. 7 press release that it will immediately start creating […]
Janssen’s respiratory panel wins 510(k) clearance
Johnson & Johnson (NYSE:JNJ) subsidiary Janssen Diagnostics said today that it won 510(k) clearance from the FDA for its Idylla respiratory panel. The diagnostic test, developed in partnership with Biocartis Group, helps physicians identify viral respiratory infections, including infection from respiratory syncytial virus and influenza virus. The company’s assay uses nasopharyngeal swabs to collect samples and […]
LabCorp completes $1.2B Chiltern buy
Diagnostics company LabCorp (NYSE:LH) said today that it has closed its $1.2 billion acquisition of contract research organization Chiltern International. Chiltern is slated to fold into the company’s Covance drug development business, which conducts clinical trials for drugmakers. “The addition of Chiltern advances a key element of LabCorp’s strategy – to bring innovative medicines to patients […]